Dalpiciclib Plus Camrelizumab for HCC Patients Who Have Previously Received ICI Treatment
Dalpiciclib Plus Camrelizumab for HCC Patients Who Have Previously Received ICI Treatment
Recruiting · NCT07238881 · Registry updated 2025-11-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dalpiciclib Plus Camrelizumab for HCC Patients Who Have Previously Received ICI Treatment | Hepatocellulcar Carcinoma | Recruiting | Phase 2 | 2025-11-20 | NCT07238881 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sun Yat-sen University | 606 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sun Yat-sen University Cancer Center | Guangzhou | China | 61 |